Clinical Trials
8 trialsNCT05700903 2026-03-02
ARCH
University of Colorado, Denver
Phase 4 Completed
NCT03641560 2025-04-08
A Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based Chemotherapy
Astellas Pharma Inc
Phase 4 Completed
NCT02918968 2024-12-09
Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer
Astellas Pharma Inc
Phase 4 Completed
NCT01977651 2024-12-06
UPWARD
Astellas Pharma Inc
Phase 4 Completed
NCT02116582 2024-12-06
A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer
Astellas Pharma Inc
Phase 4 Completed
NCT03927391 2024-06-12
REDOSE
Radboud University Medical Center
Phase 4 Completed
NCT01995513 2023-09-18
PLATO
Pfizer
Phase 4 Completed
NCT02485691 2022-05-27
CARD
Sanofi
Phase 4 Completed